-
Mashup Score: 4
PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning.
Source: www.thelancet.comCategories: General Medicine News, Oncologists2Tweet
-
Mashup Score: 1
Watch this videoclip from the Gopi Gnanasegaran presentation at #IUCS23 titled “Theragnostics in mPCa: Diagnosis and Treatment”
Source: www.youtube.comCategories: Latest Headlines, Oncologists2Tweet-
RT @urologysummit: Listen to what Gopi Gnanasegaran told at #IUCS23 about diagnostic #PSMA PET https://t.co/kgoIIHGu4m @gbanna74 @ravikanes…
-
-
Mashup Score: 0Transistor.fm - 7 month(s) ago
Transistor is the best way to create a podcast for your business. Everything you need to start your own podcast.
Source: subscribe.transistor.fmCategories: Latest Headlines, Partners & KOLsTweet-
Interested in #PSMA in #ProstateCancer? Check out insights from #AdamKinniard from @UrologyAlberta @UAlberta here: https://t.co/O8UhMwZRYv @CanUrolAssoc @urologymd1 @urethrologist @_TheUrologist_ @CuaJournal NOTICE: intended for Canadian HCPs. Sponsored by @BayerOncMed
-
-
Mashup Score: 0
Andrew Armstrong joins Andrea Miyahira in discussing a retrospective analysis of the prospective multicenter PROPHECY trial of men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide seeking to develop a liquid biopsy using circulating tumor cells (CTCs) that they can associate with outcomes in men with mCRPC and ultimately apply that to a…
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
PSMA-targeted radioligand therapy and #LiquidBiopsy characterizing #PSMA expression in men with metastatic castration-resistant #ProstateCancer. @AarmstrongDuke @DukeCancer joins @AndreaMiyahira @PCFnews to discuss the #PROPHECY trial on UroToday > https://t.co/tTiFnUVJOv https://t.co/V3GnLrNAir
-
-
Mashup Score: 1Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL - Full Text View - ClinicalTrials.gov - 8 month(s) ago
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL – Full Text View.
Source: classic.clinicaltrials.govCategories: Hem/Oncs, Latest HeadlinesTweet-
@JuddMoul @DukeGUCancer Current study @thenci Evaluating #PSMA #PET+ over time to understand what really happens w/out (over)treatment 🩻PETs q 6 months 💉💊⚡️Int’t Tx or SBRT allowed Hope to gather data in this space For many tx likely ⬆️toxicity, unclear beyond that https://t.co/1FQG105o9w
-
-
Mashup Score: 0DNA Methylation Urine Biomarkers Test Shows Promise in Diagnosing Upper Tract Urothelial Cancer - Angelo Territo & Andrea Gallioli - 10 month(s) ago
Andrea Gallioli and Angelo Territo join Sam Chang in a discussion on using DNA methylation markers to diagnose upper tract urothelial carcinoma in a single center prospective clinical trial. They evaluated the accuracy of a urine biomarker test called Bladder EpiCheck and compared it with urinary cytology. EpiCheck outperformed cytology in any aspect, with a higher sensitivity and negative…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
#WatchNow This great discussion by @stefanofanti4 on the significance of PSMA-PET imaging in #ProstateCancer. Learn about the history of #nuclearmedicine in prostate cancer and how #PSMA is changing the game > https://t.co/ZsasdWHK0O @SanRaffaeleMI @SanRaffaeleMI https://t.co/aWBreZ1pYr
-
-
Mashup Score: 2PSMA-Targeted Radioligand Therapy and Liquid Biopsy Characterizing PSMA Expression in Men with Metastatic Castration-Resistant Prostate Cancer - Andrew Armstrong - 10 month(s) ago
Andrew Armstrong joins Andrea Miyahira in discussing a retrospective analysis of the prospective multicenter PROPHECY trial of men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone or enzalutamide seeking to develop a liquid biopsy using circulating tumor cells (CTCs) that they can associate with outcomes in men with mCRPC and ultimately apply that to a…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
PSMA-targeted radioligand therapy and #LiquidBiopsy characterizing #PSMA expression in men with metastatic castration-resistant #ProstateCancer. @AarmstrongDuke @DukeCancer joins @AndreaMiyahira @PCFnews to discuss the #PROPHECY trial on UroToday > https://t.co/tTiFnUVJOv https://t.co/l9ncxhQgbu
-
-
Mashup Score: 0Prostate Cancer Clinical Trial: ESCAPE Trial - 11 month(s) ago
This is “Prostate Cancer Clinical Trial: ESCAPE Trial” by PRIMR on Vimeo, the home for high quality videos and the people who love them.
Source: VimeoCategories: Hem/Oncs, Latest HeadlinesTweet-
ESCAPE will test #PSMA in men on #ActiveSurveillance. Looking forward to multi-site collaboration. @WeillCornell @UCLAJCCC @UCSFCancer @UTSWNews @UHhospitals @TimMcClureMD @dr_coops @RobertReiterMD @wayne_brisbane @jeshoag @DrWoldu @PRIMR_MED @LantheusNews https://t.co/lbBBCgItnO
-
-
Mashup Score: 0Emerging Nomogram May Predict Outcomes After PSMA PET-Guided Salvage Radiotherapy in Patients with Prostate Cancer - 11 month(s) ago
In a multinational, multicenter study of over 1,000 patients with recurrent prostate cancer, researchers developed and validated a nomogram that achieved a 72 percent concordance index for the prediction of biochemical recurrence after PSMA PET-guided salvage radiotherapy.
Source: Diagnostic ImagingCategories: Latest Headlines, RadiologyTweet-
Emerging Nomogram May Predict Outcomes After #PSMA PET-Guided Salvage #Radiotherapy for #ProstateCancer https://t.co/BIzMb8d0u2 @ACRRFS @ACRYPS @RadiologyACR @ARRS_Radiology @SocietyAbdRad @SAR_AARC @RadiologyUcla @UTSW_Radiology @UCSFimaging @OHSURadiology #radiology #RadRes https://t.co/0bJvnPJtWS
-
-
Mashup Score: 0DNA Methylation Urine Biomarkers Test Shows Promise in Diagnosing Upper Tract Urothelial Cancer - Angelo Territo & Andrea Gallioli - 11 month(s) ago
Andrea Gallioli and Angelo Territo join Sam Chang in a discussion on using DNA methylation markers to diagnose upper tract urothelial carcinoma in a single center prospective clinical trial. They evaluated the accuracy of a urine biomarker test called Bladder EpiCheck and compared it with urinary cytology. EpiCheck outperformed cytology in any aspect, with a higher sensitivity and negative…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
#WatchNow This great discussion by @stefanofanti4 on the significance of PSMA-PET imaging in #ProstateCancer. Learn about the history of #nuclearmedicine in prostate cancer and how #PSMA is changing the game > https://t.co/ZsasdWHK0O @SanRaffaeleMI @SanRaffaeleMI https://t.co/0wi4GvEoau
-
Breaking down the recurrences, only two were within the prostate, and several would potentially been picked up had we had access to #PSMA in 2014… https://t.co/dJvdJYRGZj https://t.co/yjsBRufRqd